296 related articles for article (PubMed ID: 1458716)
21. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
Petraitiene R; Petraitis V; Kelaher AM; Sarafandi AA; Mickiene D; Groll AH; Sein T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2005 May; 49(5):2084-92. PubMed ID: 15855534
[TBL] [Abstract][Full Text] [Related]
23. Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis.
Mencacci A; Cenci E; Bacci A; Bistoni F; Romani L
J Infect Dis; 2000 Feb; 181(2):686-94. PubMed ID: 10669356
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L
Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860
[TBL] [Abstract][Full Text] [Related]
25. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
[TBL] [Abstract][Full Text] [Related]
26. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
[TBL] [Abstract][Full Text] [Related]
27. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Warn PA; Morrissey J; Moore CB; Denning DW
Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841
[TBL] [Abstract][Full Text] [Related]
28. Comparison of cilofungin and amphotericin B for therapy of murine candidiasis.
Smith KR; Lank KM; Cobbs CG; Cloud GA; Dismukes WE
Antimicrob Agents Chemother; 1990 Aug; 34(8):1619-21. PubMed ID: 2221875
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G
J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370
[TBL] [Abstract][Full Text] [Related]
30. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.
Fisher MA; Shen SH; Haddad J; Tarry WF
Antimicrob Agents Chemother; 1989 Sep; 33(9):1443-6. PubMed ID: 2554797
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
Krishnan-Natesan S; Manavathu EK; Cutright JL; Chandrasekar PH
Int J Antimicrob Agents; 2010 Jul; 36(1):33-6. PubMed ID: 20400270
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
Rouse MS; Tallan BM; Steckelberg JM; Henry NK; Wilson WR
Antimicrob Agents Chemother; 1992 Jan; 36(1):56-8. PubMed ID: 1590700
[TBL] [Abstract][Full Text] [Related]
33. Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.
MacCallum DM; Odds FC
Antimicrob Agents Chemother; 2004 Dec; 48(12):4911-4. PubMed ID: 15561880
[TBL] [Abstract][Full Text] [Related]
34. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
35. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
[TBL] [Abstract][Full Text] [Related]
36. Candida tropicalis in human disease.
Chai LY; Denning DW; Warn P
Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
[TBL] [Abstract][Full Text] [Related]
37. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Sanati H; Ramos CF; Bayer AS; Ghannoum MA
Antimicrob Agents Chemother; 1997 Jun; 41(6):1345-8. PubMed ID: 9174196
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
Morrison CJ; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
[TBL] [Abstract][Full Text] [Related]
40. Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy.
Sugar AM; Goldani LZ; Picard M
Antimicrob Agents Chemother; 1991 Oct; 35(10):2128-30. PubMed ID: 1759836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
